Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Remission of Severe Myasthenia Gravis After Massive-Dose Vitamin D Treatment.
Novel remyelination strategy for multiple sclerosis in the era of oligodendrocytopathy.
NLRP3 Inflammasome and MS/EAE.
Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study.
Fluctuations in appraisal over time in the context of stable versus non-stable health.
Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis.
Identifying Modulators of CXC Receptors 3 and 4 with Tailored Selectivity using Multi-Target Docking.
TREM2 regulates microglial cell activation in response to demyelination in vivo.
Patient-identified factors that influence spasticity in people with stroke and multiple sclerosis receiving botulinum toxin injection treatments.
VLA4 Gene Polymorphism and Susceptibility to Multiple Sclerosis in Slovaks.
Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies.
Abnormal adaptation over time of motor network recruitment in multiple sclerosis patients with fatigue.
Central Nervous System Infections With Immunomodulatory Therapies.
Longitudinal fMRI studies: Exploring brain plasticity and repair in MS.
Dimethyl Fumarate: A Review in Relapsing-Remitting MS.
Change of Th17 Lymphocytes and Treg/Th17 in Typical and Atypical Optic Neuritis.
The essential role of t cells in multiple sclerosis: A reappraisal.
Biochemical markers of neurodegeneration in hereditary diffuse leucoencephalopathy with spheroids.
Isolation of bacterial plasmid-related replication-associated circular DNA from a serum sample of a multiple sclerosis patient.
The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis.
Head Tracking Latency in Virtual Environments Revisited: Do Users with Multiple Sclerosis Notice Latency Less?
New-onset multiple sclerosis associated with adalimumab treatment in rheumatoid arthritis: a case report and literature review.
Induction of atypical EAE mediated by transgenic production of IL-6 in astrocytes in the absence of systemic IL-6.
Mesenchymal stem cells are mobilized from the bone marrow during inflammation.
Serum Biomarker gMS-Classifier2: Predicting Conversion to Clinically Definite Multiple Sclerosis.

Pages